Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 9,170.00
-420.00 (-4.38%)
At close: Apr 21, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 118.71 billion as of April 21, 2026. Its market cap has increased by 37.07% in one year.
Market Cap
118.71B
Enterprise Value
100.65B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,170.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has increased from 112.78B to 118.71B, an increase of 5.26%. That is a compound annual growth rate of 1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 118.71B | -2.34% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organoidsciences | 155.09B |
| Kyung Dong Pharmaceutical | 154.11B |
| DongKoo Bio & Pharma | 145.49B |
| PHARMARESEARCH BIO | 140.47B |
| KOREA PHARMA | 132.84B |
| HYUNDAI BIOLAND | 131.40B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 126.34B |
| Daehan Nupharm | 105.26B |